Clinical Trials in fujian, china
Locations / fujian, china
Delta Trials records 78 clinical trials conducted in fujian, china, making it a notable site of clinical research activity. These trials across 112 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 5 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in fujian has changed over time.
78
Total Trials
112
Conditions
5
Terminated since 2020
Top Conditions (112 total)
- Breast Cancer 3 trialsAll Breast Cancer trials
- Familial Alzheimer Disease (FAD) 2 trialsAll Familial Alzheimer Disease (FAD) trials
- Carcinoma, Non-Small-Cell Lung 2 trialsAll Carcinoma, Non-Small-Cell Lung trials
- Prostate Cancer 2 trialsAll Prostate Cancer trials
- Advanced Solid Tumors 2 trialsAll Advanced Solid Tumors trials
- Bullous Pemphigoid 2 trialsAll Bullous Pemphigoid trials
- Crohn's Disease 2 trialsAll Crohn's Disease trials
- Lupus Nephritis 2 trialsAll Lupus Nephritis trials
- Non-small Cell Lung Cancer 2 trialsAll Non-small Cell Lung Cancer trials
- Gastric Cancer 2 trialsAll Gastric Cancer trials
- Advanced Solid Tumor 2 trialsAll Advanced Solid Tumor trials
- Advanced Melanoma 1 trialAll Advanced Melanoma trials
- All Hormone Receptor-positive/Her2 Negative Breast Cancer trials
- Cervical Cancer 1 trialAll Cervical Cancer trials
- Breast Neoplasms 1 trialAll Breast Neoplasms trials
- Solid Tumors, Adult 1 trialAll Solid Tumors, Adult trials
- All mCRPC (Metastatic Castration-resistant Prostate Cancer) trials
- Scar, Hypertrophic 1 trialAll Scar, Hypertrophic trials
- Diffuse Large B-Cell Lymphoma 1 trialAll Diffuse Large B-Cell Lymphoma trials
- Child, Only 1 trialAll Child, Only trials